Community-based Care for Drug-resistant Tuberculosis: A Guide for Implementers
Citation: USAID TB CARE II (2017) Community-based Care for Drug-resistant Tuberculosis: A Guide for Implementers
Abstract: Many countries are in the process of establishing or scaling up treatment of drug-resistant tuberculosis (DR TB). Effectively scaling up treatment will require addressing health systems–related issues, such as task shifting to alleviate human resources shortages and greater community engagement.
A principal challenge in establishing or scaling up treatment of DR TB is deciding what model of care to implement. A crucial step is bridging the gap between the hospital and the community to ensure continuity of care. For DR TB treatment to be truly patient-centered, patients should have the option to choose the location of their treatment, including the option to be supported in their homes and communities with monthly visits to the facility for monitoring of treatment and a follow up laboratory monitoring tests.
This guide provides practical, step-by-step guidance on how to organize, implement, and monitor community-based care for DR TB. It is equally useful for program planning or supervision.
The target audience for this guide is TB program managers, governments, policy makers, nongovernmental organizations (NGOs), donors and TB advocates.
A principal challenge in establishing or scaling up treatment of DR TB is deciding what model of care to implement. A crucial step is bridging the gap between the hospital and the community to ensure continuity of care. For DR TB treatment to be truly patient-centered, patients should have the option to choose the location of their treatment, including the option to be supported in their homes and communities with monthly visits to the facility for monitoring of treatment and a follow up laboratory monitoring tests.
This guide provides practical, step-by-step guidance on how to organize, implement, and monitor community-based care for DR TB. It is equally useful for program planning or supervision.
The target audience for this guide is TB program managers, governments, policy makers, nongovernmental organizations (NGOs), donors and TB advocates.
Author(s): TB Care II
Year: 2017
Language: English
Resource Type: Guidance and Tools
Source: Other
Filed under: Community, DR-TB, Drug-resistant TB, Guidance, Guidance and Tools, Program plannning, TB care, Technical Guidance
